{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:00:25Z","timestamp":1789038025807,"version":"build-2803163510"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0217352","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T18:45:40Z","timestamp":1558637140000},"page":"e0217352","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity"],"prefix":"10.1371","volume":"14","author":[{"given":"Nahla Yassin","family":"Sahlol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-8938","authenticated-orcid":true,"given":"Marwa Salah","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-3904","authenticated-orcid":true,"given":"Lamiaa Abd El-Fattah","family":"Madkour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Metwally","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"ref1","article-title":"Principles and Practice of Hospital Medicine","author":"AE Allan","year":"2016"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: implications for disease management","volume":"26","author":"K Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","article-title":"The Color Atlas of Family Medicine","author":"RP Usatine","year":"2013"},{"issue":"4\u20135","key":"ref4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","article-title":"Diagnosis and classification of psoriasis","volume":"13","author":"SK Raychaudhuri","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"H Yeung","year":"2013","journal-title":"JAMA dermatol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/abd1806-4841.20164169","article-title":"Psoriasis: new comorbidities","volume":"91","author":"J Machado-Pinto","year":"2016","journal-title":"An. Bras. Dermatol"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/jid.2011.32","article-title":"Psoriasis and cardiovascular risk: Strength in numbers Part II","volume":"131","author":"JM Gelfand","year":"2011","journal-title":"J Investig Dermatol"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jamadermatol.2017.3225","article-title":"Alcohol-related mortality in patients with psoriasis: A population-based cohort study","volume":"153","author":"R Parisi","year":"2017","journal-title":"JAMA Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"MA Lowes","year":"2014","journal-title":"Annu. Rev. Immunol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","article-title":"The immunopathogenesis of psoriasis","volume":"33","author":"J Kim","year":"2015","journal-title":"Dermatol clin"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2230.2011.04131.x","article-title":"The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept","volume":"36","author":"A Kanelleas","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/tpj.2012.53","article-title":"Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases","volume":"13","author":"R Prieto-Perez","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cell.2008.03.026","article-title":"TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis","volume":"133","author":"H Sun","year":"2008","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"14705","DOI":"10.1016\/S0021-9258(18)77165-2","article-title":"The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein","volume":"265","author":"AW Opipari","year":"1990","journal-title":"J Biol Chem"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/jid.2011.376","article-title":"<italic>TNFAIP3<\/italic> gene polymorphisms are associated with response to TNF blockade in psoriasis","volume":"132","author":"T Tejasvi","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3892\/ijmm.2016.2514","article-title":"The inhibitory effect of A20 on the inflammatory reaction of epidermal keratinocytes","volume":"37","author":"KC Sohn","year":"2016","journal-title":"Int J Mol Med"},{"issue":"5488","key":"ref17","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","article-title":"Failure to regulate TNF-induced NF-\u03baB and cell death responses in A20-deficient mice","volume":"289","author":"EG Lee","year":"2000","journal-title":"Science"},{"key":"ref18","article-title":"TNFAIP3 (tumor necrosis factor, alpha-induced protein 3)","author":"S Rasi","year":"2009","journal-title":"Atlas of Genetic and Cytogenics in Oncology and Haematology"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.it.2013.10.005","article-title":"A20 in inflammation and autoimmunity","volume":"35","author":"L Catrysse","year":"2014","journal-title":"Trends immunol"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.4049\/jimmunol.0803313","article-title":"A20 negatively regulates T cell receptor signaling to NF-\u03baB by cleaving Malt1 ubiquitin chains","volume":"182","author":"M D\u00fcwel","year":"2009","journal-title":"J Immunol"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.4049\/jimmunol.1001051","article-title":"Cutting edge: TCR ligation triggers digital activation of NF-\u03baB","volume":"185","author":"LM Kingeter","year":"2010","journal-title":"J Immunol"},{"issue":"15","key":"ref22","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1101\/gad.1680708","article-title":"Encoding NF-\u03b1B temporal control in response to TNF: distinct roles for the negative regulators I\u03baB\u03b1 and A20","volume":"22","author":"SL Werner","year":"2008","journal-title":"Genes Dev"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.immuni.2010.07.017","article-title":"The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity","volume":"33","author":"RM Tavares","year":"2010","journal-title":"Immunity"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ni.2135","article-title":"Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis","volume":"12","author":"GE Hammer","year":"2011","journal-title":"Nat Immunol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.4049\/jimmunol.1402608","article-title":"Cutting edge: NF-\u03baB p65 and c-Rel control epidermal development and immune homeostasis in the skin","volume":"194","author":"Y Grinberg-Bleyer","year":"2015","journal-title":"J Immunol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways","volume":"41","author":"RP Nair","year":"2009","journal-title":"Nat Genet"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.766","article-title":"Association of a functional variant downstream of <italic>TNFAIP3<\/italic> with systemic lupus erythematosus","volume":"43","author":"I Adrianto","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/cdd.2011.55","article-title":"Keratinocyte-specific ablation of the NF-\u03baB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis","volume":"18","author":"S Lippens","year":"2011","journal-title":"Cell Death Differ"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"e1003750","DOI":"10.1371\/journal.pgen.1003750","article-title":"An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression","volume":"9","author":"S Wang","year":"2013","journal-title":"PLoS Genet"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/gene.2016.4","article-title":"TALEN-mediated enhancer knockout influences <italic>TNFAIP3<\/italic> gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus","volume":"17","author":"S Wang","year":"2016","journal-title":"Genes Immun"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/gene.2014.75","article-title":"Meta-analysis of the <italic>TNFAIP3<\/italic> region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseases","volume":"16","author":"J Nititham","year":"2015","journal-title":"Genes Immun"},{"issue":"7512","key":"ref32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"LV Walle","year":"2014","journal-title":"Nature"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2014.12.031","article-title":"A20 restricts ubiquitination of pro-interleukin-1\u03b2 protein complexes and suppresses NLRP3 inflammasome activity","volume":"42","author":"BH Duong","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ni.3172","article-title":"The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis","volume":"16","author":"M Onizawa","year":"2015","journal-title":"Nat immunol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4155\/cli.11.11","article-title":"Use of pharmacogenomics in psoriasis","volume":"1","author":"C Ryan","year":"2011","journal-title":"J Clin Invest"},{"issue":"7","key":"ref36","first-page":"4","article-title":"TNF-alpha inhibitors in dermatology","volume":"12","author":"KM Cordoro","year":"2007","journal-title":"Skin Therapy Lett"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/bjd.15005","article-title":"Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis","volume":"176","author":"JMPA van den Reek","year":"2017","journal-title":"Br J Dermatol"},{"issue":"16","key":"ref38","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1093\/nar\/gks521","article-title":"A miR-19 regulon that controls NF-\u03baB signaling","volume":"40","author":"MP Gantier","year":"2012","journal-title":"Nucleic acids Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"21816","DOI":"10.1074\/jbc.M111.327031","article-title":"Identifying functional microRNAs in macrophages with polarized phenotypes","volume":"287","author":"JW Graff","year":"2012","journal-title":"J Biol Chem"},{"issue":"20","key":"ref40","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1073\/pnas.1200081109","article-title":"MicroRNAs miR-125a and miR-125b constitutively activate the NF-\u03baB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)","volume":"109","author":"SW Kim","year":"2012","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1128\/CVI.00500-12","article-title":"Expression of tumor necrosis factor alpha-induced protein 3 mRNA in peripheral blood mononuclear cells negatively correlates with disease severity in psoriasis vulgaris","volume":"19","author":"X Jiang","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaad.2013.08.042","article-title":"Research gaps in psoriasis: opportunities for future studies","volume":"70","author":"C Ryan","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187221309787158399","article-title":"NF-\u03baB links keratinocytes and lymphocytes in the pathogenesis of psoriasis","volume":"3","author":"D Tsuruta","year":"2009","journal-title":"Recent Pat InflammAllergy Drug Discov"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"e0180481","DOI":"10.1371\/journal.pone.0180481","article-title":"Hypomorphic A20 expression confers susceptibility to psoriasis","volume":"12","author":"A Aki","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jid.2018.06.191","article-title":"Keratinocyte Expression of A20\/<italic>TNFAIP3<\/italic> Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis","volume":"139","author":"M Devos","year":"2019","journal-title":"J Invest Dermatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clim.2018.03.009","article-title":"<italic>TNFAIP3<\/italic> haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6","volume":"191","author":"C Franco-Jarava","year":"2018","journal-title":"Clin Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-kappaB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases","volume":"8","author":"I Aksentijevich","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.039","article-title":"Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders","volume":"141","author":"T Kadowaki","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjd.14481","article-title":"Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol","volume":"175","author":"X Liu","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bjd.14656","article-title":"The evolving regulatory role of ubiquitin-editing enzyme A20 in psoriasis during calcipotriol treatment","volume":"175","author":"B Dyring-Andersen","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3892\/etm.2015.2887","article-title":"Effect of the topical application of calcipotriol on the expression levels of zinc finger protein A20and nuclear factor-\u03baB in the skin lesions of patients with psoriasis vulgaris","volume":"11","author":"YJ Tang","year":"2016","journal-title":"Exp Ther Med"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri3313","article-title":"A20: linking a complex regulator of ubiquitylation to immunity and human disease","volume":"12","author":"A Ma","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-\u03b1, IFN-\u03b3, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"O Arican","year":"2005","journal-title":"Mediators Inflamm"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1365-2133.2010.09990.x","article-title":"Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris","volume":"163","author":"KS Anderson","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.4049\/jimmunol.0903133","article-title":"IL-17 activates the canonical NF-\u03baB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16","volume":"184","author":"S Xie","year":"2010","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"17971","DOI":"10.1016\/S0021-9258(19)37138-8","article-title":"Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements","volume":"267","author":"A Krikos","year":"1992","journal-title":"J Biol Chem"},{"issue":"12","key":"ref57","first-page":"7001","article-title":"African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity","volume":"184","author":"JP Lodolce","year":"2010","journal-title":"The J Immunol 2010"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/leu.2009.234","article-title":"A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma","volume":"24","author":"E Chanudet","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"ref59","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/ijc.25579","article-title":"Sustained NF kappa B activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus","volume":"128","author":"LP Frenzel","year":"2011","journal-title":"Int J Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0217352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T14:45:00Z","timestamp":1663512300000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0217352"}},"subtitle":[],"editor":[{"given":"Benjamin Edward","family":"Rich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0217352","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}